Osteoprotegerin promotes proliferation and migration of human microvascular endothelial cells

Life Sciences 2007 (2007) Proc Life Sciences, PC374

Poster Communications: Osteoprotegerin promotes proliferation and migration of human microvascular endothelial cells

M. Kobayashi-Sakamoto1, E. Isogai1, K. Hirose2, I. Chiba1

1. Department of Preventive Dentistry, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Hokkaido, Japan. 2. Department of Preventive Dentistry, School of Dentistry, Ohu University, Koriyaka, Fukushima, Japan.

View other abstracts by:


Objective: Osteoprotegerin (OPG), a member of the TNF (tumor necrosis factor) receptor superfamily, is a key regulator of osteoclastogenesis. Recently, we reported that endothelial cells produce high level of OPG in response to Escherichia coli lipopolysaccharide1. We also indicated that OPG treatment protects human microvascular endothelial cells (HMVECs) from detachment and apoptotic cell death induced by cysteine proteases that are produced by Porphyromonas gingivalis2. These results suggest that OPG can be involved in the immunological functions of endothelial cells. However, the potential role of OPG in endothelial cell biology is unknown. In this study, we investigated the effects of OPG on HMVECs. Methods: HMVECs were seeded in 96-well plates and incubated for 36 h in human serum-free medium (H-SFM) with increasing doses of OPG (20,100 and 500 ng/ml). Cell proliferation was assessed by a tetrazolium (WST-8) reduction assay. Cell migration was assessed using FALCON Cell Culture FluoroBlok Inserts, which are inserts coated with vitronectin or fibronectin. Two integrin receptors for vitronectin, namely, integrin αvβ3 and αvβ5are expressed on endothelial cells; in certain experiments, therefore, cells in suspension were pre-treated with anti-αvβ3 or anti-αvβ5 antibodies. Results: The OPG treatment induced the proliferation of HMVECs in a dose-dependent manner. The cell migration assay showed that OPG induced cell migration on vitronectin in a dose-dependent manner, whereas no significant increase in migration occurred on fibronectin. In addition, a blocking antibody to αvβ3, but not to αvβ5, significantly inhibits OPG-induced cell migration. These results indicate that OPG promotes αvβ3-dependent endothelial cell migration. Conclusions: Our results reveal that the OPG is an important factor for the proliferation and migration of endothelial cells. Because integrin αvβ3 is highly expressed in angiogenic endothelial cells but not in quiescent endothelial cells, our results also suggest that OPG can regulate the migration of endothelial cells by influencing αvβ3 expression. This suggests that OPG plays a role in neovessel formation under physiological and pathological conditions.



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type